Dermatologicals in Western Europe

Delivery

This report comes in PPT.

Key findings

Sales driven by growing number of allergy sufferers

Many people in Western Europe suffer from various types of allergies and this number is constantly growing. Children who are exposed to allergies from birth are at particular risk as their bodies have reduced immunity. In addition to environmental factors, genes have an impact on the development of allergies, so the problem will grow, being passed onto future generations. Moreover, climate, fitness trends and increasing sports activities are additional factors generating constant demand for dermatologicals.

Positive performance despite Coronavirus (COVID-19) outbreak

While growth of topical antifungals has been hindered by the pandemic, germicidals/atiseptics saw positive growth due to high demand for products with antibacterial positioning. In turn, over-zealous use of disinfectants resulting in skin irritations leads to greater interest in antipruritics and paediatric dermatologicals.

Western Europe is a consolidated market

Across Western Europe, dermatologicals remains a relatively consolidated market as a whole, with the top 1-5 ranked companies, mainly European players, in the region holding a 35% share.

Chemists/Pharmacies is the key channel in the majority of markets

Dermatologicals are most commonly purchased via chemists/pharmacies in Western Europe. However, drugstores/parapharmacies as well as grocery retailers (often healthfood shops), due to the convenience factor, receive more and more attention. Lower prices, convenience and discretion support a shift to e-commerce

Dermatologicals has potential in Western Europe

Dermatologicals in Western Europe is forecast to see a 1% constant value CAGR over the 2020-2025 period supported by increased prevalence of skin allergies and seasonality. The largest market Germany, accounting for over 20% of regional sales in 2020, will continue to drive dermatologicals value growth.